Although myelodysplastic syndromes and myeloproliferative disorders appear to have entirely different pathophysiological mechanisms, the existence of conditions with overlapping features is well established. The World Health Organization (WHO) classification of the myeloid neoplasms introduced the category of myelodysplastic/myeloproliferative diseases, which includes myeloid disorders that have both dysplastic and proliferative features at the time of initial presentation and that are difficult to assign to either the myelodysplastic or myeloproliferative group of diseases. The following disorders belong to this category: chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia, juvenile myelomonocytic leukemia, and myelodysplastic/myeloproliferative disease, unclassifiable (MDS/MPD, U).

Myelodysplastic/myeloproliferative disorders

MALCOVATI, LUCA;CAZZOLA, MARIO
2008-01-01

Abstract

Although myelodysplastic syndromes and myeloproliferative disorders appear to have entirely different pathophysiological mechanisms, the existence of conditions with overlapping features is well established. The World Health Organization (WHO) classification of the myeloid neoplasms introduced the category of myelodysplastic/myeloproliferative diseases, which includes myeloid disorders that have both dysplastic and proliferative features at the time of initial presentation and that are difficult to assign to either the myelodysplastic or myeloproliferative group of diseases. The following disorders belong to this category: chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia, juvenile myelomonocytic leukemia, and myelodysplastic/myeloproliferative disease, unclassifiable (MDS/MPD, U).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/142192
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 20
social impact